Article

Staining patterns vital to early dry eye diagnosis

A few properly placed drops of lissamine green can reveal staining patterns that are key to diagnosing dry-eye syndrome earlier than possible with other methods, according to new research from the University of Texas Southwestern Medical Center.

Dallas-A few properly placed drops of lissamine green can reveal staining patterns that are key to diagnosing dry-eye syndrome earlier than possible with other methods, according to new research from the University of Texas Southwestern Medical Center.

"What this research showed is that the degree and pattern of staining was a good, objective indicator of the severity of the tear deficiency," said James McCulley, MD, chairman of ophthalmology at the institution and senior author of the study.

In an article published in the July issue of Eye and Contact Lens (33[4]:177-179), he and colleagues identified three basic patterns indicating progressively dangerous conditions:

"If an ophthalmologist uses the most commonly used stain, which is fluorescein, [then he or she is] going to miss the first two stages of the development of dry eye and, consequently, miss a lot of diagnoses," said Dr. McCulley, also director of the Theodore and Mary Beasley Laboratory for Ocular Surface Research and the Jean H. & John T. Walter Jr. Center for Research in Age-Related Macular Degeneration.

Early diagnosis of dry eye is important because more treatment options are available in the beginning stages of the syndrome, further progression of the disease can be prevented, and other conditions signaled by dry eye, such as lupus or rheumatoid arthritis, can be identified sooner.

Grants from the National Institutes of Health and Research to Prevent Blindness funded the study.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
© 2025 MJH Life Sciences

All rights reserved.